Geron Corp. buy Slaandjivaa
Start price
16.01.18
/
50%
€1.94
Target price
01.03.18
€2.26
Performance (%)
8.12%
End price
01.03.18
€2.10
Summary
This prediction ended on 01.03.18 with a price of €2.10. With a performance of 8.12%, the BUY prediction by Slaandjivaa for Geron Corp. closed with a slight gain. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Geron Corp. | 4.823% | 4.823% | 23.070% | -52.182% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by Slaandjivaa for this prediction
In the thread Geron Corp. diskutieren
Gerne Geron
https://seekingalpha.com/article/4137225-toxicity-gerons-imetelstat-may-lead-accelerated-fda-approval